Document is current
Any future updates will be listed below
-
Authors
Cao, Wenjiao
Shen, Lu
Zhang, Qinyu
Huang, Yating
Sun, Junyan
Cheng, Zixin
Xu, Jing
Zhang, Qiuwan
Lai, Dongmei
-
Funding
Funding for this research was provided by:
Medical Science and Technology Talents Support Project of IPMCH (Honghu Plan-HHJH2409)
Opening Project of Shanghai Key Laboratory of Embryo Original Diseases (Shelab202305)
National Natural Science Foundation of China (No. 82271664)
Shanghai Clinical Research Center for Cell Therapy, China (No. 23J41900100)
Research Projects of Shanghai Municipal Council for Science and Technology (20JC1412100)
Opening Project of Shanghai Key Laboratory of Embryo Original Diseases (Shelab2022ZD01)
- License Information
-
More Information
Article History
Received: 14 November 2025
Accepted: 9 May 2026
First Online: 18 May 2026
Declarations
:
: This study, including the collection of human placental tissues and all animal experiments, was reviewed and approved under a single, unified protocol (Approval No. GKLW 2020-34) by the Institutional Ethics Committee of the International Peace Maternal and Child Health Hospital. Written informed consent was obtained from all human tissue donors prior to collection. The approval title was: “SPECT/MRI composite nanofluorescence probe for tracking and repairing mechanism of stem cells in premature ovarian failure,” and the approval date was 2020-09-01.
: Not applicable.
: The authors declare no competing interests.
